Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera

Table 2

(a) Numbers and rates of nodes detected by Tc and/or ICG

	Tc
	Positive	Negative	Total
ICG
Positive	167 (75.9%)	48 (21.8%)	215 (97.7%)
Negative	5 (2.3%)	0 (0.0%)	5 (2.3%)
Total	172 (78.2%)	48 (21.8%)	220 (100.0%)

(b) Numbers and rates of patients with at least one node detected by Tc and/or ICG

	Tc
	Positive	Negative	Total
ICG
Positive	95 (96.0%)	2 (2.0%)	97 (98.0%)
Negative	2 (2.0%)	0 (0,0%)	2 (2.0%)
Total	97 (98.0%)	2 (2.0%)	99 (100.0%)

(c) Numbers and rates of tumor-affected SLN detected by Tc and/or ICG

	Tc
	Positive	Negative	Total
ICG
Positive	23 (82.1%)	4 (14.3%)	27 (96.4%)
Negative	1 (3.6%)	0 (0,0%)	1 (3.6%)
Total	24 (85.7%)	4 (14.3%)	28 (100.0%)

(d) Numbers and rates of patients with at least one tumor-affected SLN detected by Tc^99m and/or ICG

	Tc
	Positive	Negative	Total
ICG
Positive	20 (95.2%)	1 (4.8%)	21 (100.0%)
Negative	0 (0.0%)	0 (0.0%)	0 (0.0%)
Total	20 (95.2%)	1 (4.8%)	21 (100.0%)